Volume 15, Issue 3, April 2012

Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials

• Abstract
• View article

Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults

• Abstract
• View article
• Supplementary data

Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree

• Abstract
• View article
• Supplementary data

Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety

• Abstract
• View article

Increased hippocampal tau phosphorylation and axonal mitochondrial transport in a mouse model of chronic stress

• Abstract
• View article

Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study

• Abstract
• View article

Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice

• Abstract
• View article

Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression

• Abstract
• View article

Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration

• Abstract
• View article

Corrigendum: Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration – CORRIGENDUM

• Extract
• View article

Evidence-based pharmacotherapy of panic disorder: an update

• Abstract
• View article

Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal

• Abstract
• View article